New high-affinity monoclonal antibodies against shiga toxin 1 facilitate the detection of hybrid Stx1/Stx2 In vivo

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Skinner, Craig ^a   Patfield, Stephanie ^a   Stanker, Larry H ^a   Fratamico, Pina ^b   He, Xiaohua ^a  

^a WESTERN REGIONAL RESEARCH CENTER   (United States)

^b EASTERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY STX1-1; MONOCLONAL ANTIBODY STX1-2; MONOCLONAL ANTIBODY STX1-3; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2; EPITOPE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CELL PROTECTION; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; LIMIT OF DETECTION; MOUSE; NONHUMAN; SENSITIVITY AND SPECIFICITY; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; TOXIN ANALYSIS; TOXIN STRUCTURE; VERO CELL LINE; ANIMAL; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; MICE; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; SHIGA TOXIN 1; SHIGA TOXIN 2;

EID: 84902523423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099854     Document Type: Article

References (34)

1. Gaston MA, Pellino CA, Weiss AA (2013) Failure of manganese to protect from Shiga toxin. PLoS One 8: e69823.
2. Ojha SC, Yean Yean C, Ismail A, Singh KK (2013) A pentaplex PCR assay for the detection and differentiation of Shigella species. Biomed Res Int 2013: 412370.
3. Cantey JR (1985) Shiga toxin - an expanding role in the pathogenesis of infectious diseases. J Infect Dis 151: 766-771.
4. Schmidt H (2001) Shiga-toxin-converting bacteriophages. Res Microbiol 152: 687-695.
5. Allison HE (2007) Stx-phages: drivers and mediators of the evolution of STEC and STEC-like pathogens. Future Microbiol 2: 165-174.
6. Herold S, Karch H, Schmidt H (2004) Shiga toxin-encoding bacteriophages - genomes in motion. Int J Med Microbiol 294: 115-121. (Pubitemid 39281041)
7. Muthing J, Meisen I, Zhang W, Bielaszewska M, Mormann M, et al. (2012) Promiscuous Shiga toxin 2e and its intimate relationship to Forssman. Glycobiology 22: 849-862.
8. Skinner C, McMahon S, Rasooly R, Carter JM, He X (2013) Purification and characterization of shiga toxin 2f, an immunologically unrelated subtype of shiga toxin 2. PLoS One 8: e59760.
9. He X, Qi W, Quinones B, McMahon S, Cooley M, et al. (2011) Sensitive detection of Shiga Toxin 2 and some of its variants in environmental samples by a novel immuno-PCR assay. Appl Environ Microbiol 77: 3558-3564.
10. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, et al. (2012) Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol 50: 2951-2963.
11. Fuller CA, Pellino CA, Flagler MJ, Strasser JE, Weiss AA (2011) Shiga toxin subtypes display dramatic differences in potency. Infect Immun 79: 1329-1337.
12. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, et al. (1993) Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61: 3392-3402. (Pubitemid 23223431)
13. Siegler RL, Obrig TG, Pysher TJ, Tesh VL, Denkers ND, et al. (2003) Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18: 92-96. (Pubitemid 41490292)
14. Moxley RA (2000) Edema disease. Vet Clin North Am Food Anim Pract 16: 175-185.
15. Friedrich AW, Borell J, Bielaszewska M, Fruth A, Tschape H, et al. (2003) Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J Clin Microbiol 41: 2448-2453. (Pubitemid 36712450)
16. Burk C, Dietrich R, Acar G, Moravek M, Bulte M, et al. (2003) Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin. J Clin Microbiol 41: 2106-2112. (Pubitemid 36576542)
17. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, et al. (2002) Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185: 74-84. (Pubitemid 34043019)
18. Weinstein DL, Jackson MP, Perera LP, Holmes RK, O'Brien AD (1989) In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity. Infect Immun 57: 3743-3750. (Pubitemid 20001242)
19. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, et al. (2000) Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 181: 664-670. (Pubitemid 30131837)
20. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342: 1930-1936. (Pubitemid 30419087)
21. McGannon CM, Fuller CA, Weiss AA (2010) Different classes of antibiotics differentially influence shiga toxin production. Antimicrob Agents Chemother 54: 3790-3798.
22. Cheng LW, Henderson TD, Patfield S, Stanker LH, He X (2013) Mouse in vivo neutralization of Escherichia coli Shiga toxin 2 with monoclonal antibodies. Toxins (Basel) 5: 1845-1858.
23. Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H (2004) Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 17: 926-941, table of contents. (Pubitemid 39372524)
24. Yamagami S, Motoki M, Kimura T, Izumi H, Takeda T, et al. (2001) Efficacy of postinfection treatment with anti-Shiga toxin (Stx) 2 humanized monoclonal antibody TMA-15 in mice lethally challenged with Stx-producing Escherichia coli. J Infect Dis 184: 738-742. (Pubitemid 32826425)
25. Smith MJ, Teel LD, Carvalho HM, Melton-Celsa AR, O'Brien AD (2006) Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2. Vaccine 24: 4122-4129.
26. Beutin L, Steinruck H, Krause G, Steege K, Haby S, et al. (2007) Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources. J Appl Microbiol 102: 630-639.
27. Feng PC, Jinneman K, Scheutz F, Monday SR (2011) Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes. Appl Environ Microbiol 77: 6699-6702.
28. Skinner C, Patfield S, Stanker L, He X (2013) Development of monoclonal antibodies and immunoassays for sensitive and specific detection of shiga toxin stx2f. PLoS One 8: e76563.
29. He X, McMahon S, Skinner C, Merrill P, Scotcher MC, et al. (2012) Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk. J Immunol Methods.
30. Head SC, Karmali MA, Lingwood CA (1991) Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem 266: 3617-3621. (Pubitemid 21909257)
31. Nassar FJ, Rahal EA, Sabra A, Matar GM (2013) Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response. Foodborne Pathog Dis 10: 805-812.
32. Johannes L, Romer W (2010) Shiga toxins - from cell biology to biomedical applications. Nat Rev Microbiol 8: 105-116.
33. He X, Quinones B, McMahon S, Mandrell RE (2012) A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli. Toxins (Basel) 4: 487-504.
34. He X, Patfield S, Hnasko R, Rasooly R, Mandrell RE (2013) A Polyclonal Antibody Based Immunoassay Detects Seven Subtypes of Shiga Toxin 2 Produced by Escherichia coli in Human and Environmental Samples. PLoS ONE 8: e76368.